Ionizing radiation-induced DNA damage, response, and repair

Antioxidants and Redox Signaling

Volumn 21, Issue 2, 2014, Pages 251-259

  Santivasi, Wil L ^a   Xia, Fen ^a  

^a THE OHIO STATE UNIVERSITY COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ATM PROTEIN; ATR PROTEIN; DNA DEPENDENT PROTEIN KINASE; DNA POLYMERASE; DOUBLE STRANDED DNA; EPIDERMAL GROWTH FACTOR RECEPTOR; ERLOTINIB; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE 1; NICOTINAMIDE ADENINE DINUCLEOTIDE ADENOSINE DIPHOSPHATE RIBOSYLTRANSFERASE INHIBITOR; PHOSPHATIDYLINOSITOL 3 KINASE;

APOPTOSIS; BREAST CANCER; CELL CYCLE CHECKPOINT; CELL CYCLE G2 PHASE; CELL CYCLE S PHASE; CELL KILLING; CROSS LINKING; DEPOLYMERIZATION; DNA DAMAGE; DNA END JOINING REPAIR; DNA REPAIR; DNA RESPONSIVE ELEMENT; DNA STRAND BREAKAGE; DOUBLE STRANDED DNA BREAK; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; GENOMIC INSTABILITY; HOMOLOGOUS RECOMBINATION; HUMAN; IONIZING RADIATION; M PHASE CELL CYCLE CHECKPOINT; NONHUMAN; OVERALL SURVIVAL; PHASE 1 CLINICAL TRIAL (TOPIC); PHASE 2 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; PROGRESSION FREE SURVIVAL; PROTEIN PROTEIN INTERACTION; RADIATION PROTECTION; REVIEW; S PHASE CELL CYCLE CHECKPOINT; TUMOR CELL; GENETICS; NEOPLASMS; PATHOLOGY; RADIATION RESPONSE;

CELL CYCLE CHECKPOINTS; DNA BREAKS, DOUBLE-STRANDED; DNA DAMAGE; DNA REPAIR; HUMANS; NEOPLASMS; RADIATION, IONIZING;

EID: 84902505887     PISSN: 15230864     EISSN: 15577716     Source Type: Journal    
DOI: 10.1089/ars.2013.5668     Document Type: Review

References (90)

1. Alberts B, Johnson A, Lewis J, Raff M, Roberts K, and Walter P. Molecular Biology of the Cell. 5th Ed., Oxford: Garland Science, 2008
2. Ame JC, Spenlehauer C, and de Murcia G. The PARP superfamily. Bioessays 26: 882-893, 2004 (Pubitemid 39128102)
3. Bae JS, Roh JL, Lee SW, Kim SB, Kim JS, Lee JH, Choi SH, Nam SY, and Kim SY. Laryngeal edema after radiotherapy in patients with squamous cell carcinomas of the larynx and hypopharynx. Oral Oncol 48: 853-858, 2012
4. Banerjee S and Kaye S: PARP inhibitors in BRCA genemutated ovarian cancer and beyond. Curr Oncol Rep 13: 442- 449, 2011
5. Barbarino R, Janniello D, Morelli P, Falco MD, Cicchetti S, DiMurro L, Tortorelli G, Bagala P, DiCristino D, Murgia A, Terenzi S, Ponti E, Tolu B, and Santoni R. Fatigue in patients undergoing radiation therapy: an observational study. Minerva Med 104: 185-191, 2013
6. Barlow C, Brown KD, Deng CX, Tagle DA, and Wynshaw- Boris A. Atm selectively regulates distinct p-53-dependent cell-cycle checkpoint and apoptotic pathways. Nat Genet 17: 453-456, 1997 (Pubitemid 27518396)
7. Barnett GC, West CML, Dunning AM, Elliott RM, Coles CE, Pharoah PDP, and Burnet NG. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype. Nat Rev Cancer 9: 134-142, 2009
8. Bartek J and Lukas J. Ch1 and Chk2 kinases in checkpoint control and cancer. Cancer Cell 3: 421-429, 2003 (Pubitemid 38340288)
9. Begg AC, Stewart FA, and Vens C. Strategies to improve radiotherapy with targeted drugs. Nat Rev Cancer 11: 239- 253, 2011
10. Brenneman MA, Wagener BM, Miller CA, Allen C, and Nickoloff JA. XRCC3 controls the fidelity of homologous recombination. Mol Cell 10: 387-395, 2002
11. Brown EJ and Baltimore D. Essential and dispensable roles of ATR in cell cycle arrest and genome maintenance. Genes Dev 17: 615-628, 2003 (Pubitemid 36307546)
12. Bryant HE, Schultz N, Thomas HD, Parker KM, Flower D, Lopez E, Kyle S, Meuth M, Curtin NJ, and Helleday T. Specific killing of BRCA2-deficient tumours with inhibitors of poly(ADP-ribose) polymerase. Nature 434: 913-917, 2005 (Pubitemid 40559005)
13. Bucher N and Britten CD. G2 checkpoint abrogation and checkpoint kinase-1 targeting in the treatment of cancer. Br J Cancer 98: 523-528, 2008 (Pubitemid 351214533)
14. Burma S and Chen DJ: Role of DNA-PK in the cellular response to DNA double-strand breaks. DNA Repair (Amst) 3: 909-918, 2004 (Pubitemid 38997932)
15. Capelle L, Warkentin H, MacKenzie M, Joseph K, Gabos Z, Perves N, Tankel K, Chafe S, Amanie J, Ghosh S, Parliament M, and Abdulkarim B. Skin-sparing helical tomotherapy vs. 3D-conformal radiotherapy for adjuvant breast radiotherapy: in vivo skin dosimetry study. Int J Radiat Oncol Biol Phys 83: 583-590, 2012
16. Chapman JR, Barral P, Vannier JB, Borel V, Steger M, Tomas- Loba A, Sartori AA, Adams IR, Batista FD, and Boulton SJ. RIF1 is essential for 53BP1-dependent nonhomologous end joining and suppression of DNA double-strand break resection. Mol Cell 49: 858-871, 2013
17. Chen L, Nievera CJ, Lee AYL, and Wu X. Cell cycledependent complex formation of BRCA1-CtIP-MRN is important for DNA double-strand break repair. J Biol Chem 283: 7713-7720, 2008
18. Dasika GK, Lin SC, Zhao S, Sung P, Tomkinson A, and Lee EY. DNA damage-induced cell cycle checkpoints and DNA strand break repair in development and tumorigenesis. Oncogene 18: 7883-7899, 1999 (Pubitemid 30066234)
19. Delaney G, Jacob S, Featherstone C, and Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guides. Cancer 104: 1129-1137, 2005 (Pubitemid 41278947)
20. Delanian S, Lefaix JL, and Pradat PF. Radiation-induced neuropathy in cancer survivors. Radiother Oncol 105: 273- 282, 2012
21. Dennis K, Zhang L, Lutz S, van Baardwijk A, van der Linden Y, Holt T, Arnalot PF, Lagrange JL, Maranzano E, Liu R, Wong KH, Wong LC, Vassiliou V, Corn BW, De Angelis C, Holden L, Wong CS, and Chow E. International patterns in the management of radiation therapy-induced nausea and vomiting. Radiat Oncol Biol 84: e49-e60, 2012
22. Ditch S and Paull TT. The ATM protein kinase and cellular redox signaling: beyond the DNA damage response. Trends Biochem Sci 37: 15-22, 2012
23. Doble BW and Woodgett JR. GSK-3: tricks of the trade for a multi-tasking kinase. J Cell Sci 116: 1175-1186, 2003 (Pubitemid 36410657)
24. Efimova EV, Mauceri HJ, Golden DW, Labay E, Bindokas VP, Darga TE, Chakraborty C, Barreto-Andrade JC, Crawley C, Sutton HG, Kron SJ, and Weichselbaum RR. Poly(ADPribose) polymerase inhibitor induces accelerated senescence in irradiated breast cancer cells and tumors. Cancer Res 70: 6277, 2010
25. Farmer H, McCabe N, Lord CJ, Tutt AN, Johnson DA, Richardson TB, Santarosa M, Dillon KJ, Hickson I, Knights C, Martin NM, Jackson SP, Smith GC, and Ashworth A. Targeting the DNA repair defect in BRCA mutant cells as a therapeutic strategy. Nature 434: 917-921, 2005 (Pubitemid 40559006)
26. Fattah F, Lee EH, Weisensel N, Wang Y, Lichter N, and Hendrickson EA. Ku regulates the non-homologous end joining pathway choice of DNA double-strand break repair in human somatic cells. PLoS Genet 6: e10000855, 2010
27. Feng L, Fong KW, Wang J, Wang W, and Chen J. RIF1 counteracts BRCA1-mediated end resection during DNA repair. J Biol Chem 288: 11135-11143, 2013
28. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M, Mortimer P, Swaisland H, Lau A, O'Connor MJ, Ashworth A, Carmicheal J, Kaye SB, Schellens JH, and de Bono JS. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361: 123-134, 2009
29. Frosina G. DNA repair and resistance of gliomas to chemotherapy and radiotherapy. Mol Cancer Res 7: 989-999, 2009
30. Furnari B, Rhind N, and Russell P. Cdc25 mitotic inducer targeted by Chk1 DNA damage checkpoint kinase. Science 277: 1495-1497, 1997 (Pubitemid 27449235)
31. Gattei M, Zhou BB, Hobson K, Scott S, Young D, and Khanna KK. Ataxia telangiectasia mutated (ATM) kinase and ATM and Rad3 related kinase mediate phosphorylation of BRCA1 at distinct and overlapping sites. J Biol Chem 276: 17276-17280, 2001
32. Goetz JD, Motycka TA, Han M, Jasin M, and Tomkinson AE. Reduced repair of DNA double-strand breaks by homologous recombination in a DNA ligase I-deficient human cell line. DNA Repair (Amst) 4: 649-654, 2005 (Pubitemid 40720307)
33. Grallert B and Boye E. The multiple facets of the intra-S checkpoint. Cell Cycle 7: 2315-2320, 2008
34. Gudmundsdottir K and Ashworth A. The roles of BRCA1 and BRCA2 and associated proteins in the maintenance of genomic stability. Oncogene 25: 5864-5874, 2006 (Pubitemid 44453442)
35. Haffty BG and Wilson LD. (Eds). Handbook of Radiation Oncology: Basic Principles and Clinical Protocols. Boston, MA: Jones and Bartlett, 2009, pp. 41-72
36. Hill R and Lee PWK. The DNA-dependent protein kinase (DNA-PK): more than just a case of making ends meet? Cell Cycle 9: 3460-3469, 2010
37. Iliakis G, Wang H, Perrault AR, Boecker W, Rosidi B, Windhofer F, Wu W, Guan J, Terzoudi G, and Pantelias G. Mechanisms of DNA double strand break repair and chromosome aberration formation. Cytogenet Genome Res 104: 14-20, 2004 (Pubitemid 38721048)
38. Incrocci L and Jensen PT. Pelvic radiotherapy and sexual function in men and women. J Sex Med 10 Suppl 1: 53-64, 2013
39. Jazayeri A, Falck J, Lukas C, Bartek J, Smith GC, Lukas J, and Jackson SP. ATM- and cell cycle-dependent regulation of ATR in response to DNA double-strand breaks. Nat Cell Biol 8: 37-45, 2006 (Pubitemid 43064795)
40. Jossen R and Bermejo R. The DNA damage checkpoint response to replication stress: A game of forks. Front Genet 4: 26, 2013
41. Khan HA and Alhomida AS. A review of the logistic role of L-carnitine in the management of radiation toxicicity and radiotherapy side effects. J Appl Toxicol 31: 707-713, 2011
42. Knobbe CB, Merlo A, and Reifenberger G. Pten signaling in gliomas. Neuro Oncol 4: 196-211, 2002
43. Korur S, Huber RM, Sivasankaran B, Petrich M, Morin P, Hemmings BA, Merlo A, and Lino MM. GSK3b regulates differentiation and growth arrest in glioblastoma. PLoS One 4: e7443, 2009
44. Lee JH and Paull TT. Activation and regulation of ATM kinase activity in response to DNA double-strand breaks. Oncogene 26: 7741-7748, 2007 (Pubitemid 350242454)
45. Lee JH, Kim KH, Morio T, and Kim H. Ataxia-telangiectasiamutated- dependent activation of Ku in human fibroblasts exposed to hydrogen peroxide. Ann N Y Acad Sci 1091: 76-82, 2006 (Pubitemid 47092226)
46. Li L, Wang H, Yang ES, Arteaga CL, and Xia F. Erlotinib attenuates homologous recombinational repair of chromosomal breaks in human breast cancer cells. Cancer Res 68: 9141-9146, 2008
47. Li M, Fang X, Baker DJ, Guo L, Gao X, Wei Z, Han S, van Deursen JM, and Zhang P. The ATM-p53 pathway suppresses aneuoploidy-induced tumorigenesis. Proc Natl Acad Sci USA 107: 14188-14193, 2010
48. Liang J and Slingerland JM. Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression. Cell Cycle 4: 339-345, 2003
49. Lieber MR, Ma Y, Pannicke U, and Schwarz K. Mechanism and regulation of human non-homologous DNA end-joining. Nat Rev Mol Cell Biol 4: 712-720, 2003 (Pubitemid 37082186)
50. Ma Y, Pannicke U, Schwarz K, and Lieber MR. Hairpin opening and overhang processing by an artemis/DNAdependent protein kinase complex in nonhomologous end joining and V(D)J recombination. Cell 108: 781-794, 2002 (Pubitemid 34327530)
51. Maloisel L, Fabre F, and Gangloff S. DNA polymerase delta is preferentially recruited during homologous recombination to promote heteroduplex DNA extension. Mol Cell Biol 28: 1373-1382, 2008 (Pubitemid 351214138)
52. Mao Z, Bozzella M, Seluanov A, and Gorbunova V. Comparison of nonhomologous end joining and homologous recombination in human cells. DNA Repair (Amst) 7: 1765-1771, 2008
53. Massague J. G1 cell-cycle control and cancer. Nature 432: 298-306, 2004 (Pubitemid 39551657)
54. May KM and Hardwick KG. The spindle checkpoint. J Cell Sci 119: 4139-4142, 2006 (Pubitemid 44774020)
55. Miyagawa K. Clinical relevance of the homologous recombination machinery in cancer therapy. Cancer Sci 99: 187-194, 2008 (Pubitemid 351228469)
56. Moll U, Lau R, Sypes MA, Gupta MM, and Anderson CW: DNA-PK, the DNA-activated protein kinase, is differentially expressed in normal and malignant human tissues. Oncogene 18: 3114-3126, 1999 (Pubitemid 29261232)
57. Moynahan ME and Jasin M. Mitotic homologous recombination maintains genomic stability and suppresses tumorigenesis. Nat Rev Mol Cell Biol 11: 196, 2010
58. Nur-E-Kamal A, Li TK, Zhang A, Qi H, Hars ES, and Liu LF. Single-stranded DNA induces ataxia telangiectasia mutant (ATM)/p53-dependent DNA damage and apoptotic signals. J Biol Chem 278: 12475-12481, 2003 (Pubitemid 36800235)
59. Ou YH, Chung PH, Sun TP, and Shieh SY. P53 C-terminal phosphorylation by CHK1 and CHK2 participates in the regulation of DNA-damage-induced C-terminal acetylation. Mol Biol Cell 16: 1684-1695, 2005
60. Paez J and Sellers W. PI3K/PTEN/Akt pathway: A critical mediator of oncogenic signaling. Cancer Treat Res 115: 145-167, 2004
61. Powell SN and Kachnic LA. Roles of BRCA1 and BRCA2 in homologous recombination, DNA replication fidelity and the cellular response to ionizing radiation. Oncogene 22: 5784-5791, 2003
62. Rhind N and Russell P. Signaling pathways that regulate cell division. Cold Spring Harb Perspect Biol 4: a005942, 2012
63. Schneider U, Besserer J, and Mack A. Hypofractionated radiotherapy has the potential for second cancer reduction. Theor Biol Med Model 7: 4, 2010
64. Shibata A, Conrad S, Birraux J, Geuting V, Barton O, Ismail A, Kakarougkas A, Meek K, Taucher-Scholz G, Lobrich M, and Jeggo PA. Factors determining DNA double-strand break repair pathway choice in G2 phase. EMBO J 30: 1079- 1092, 2011
65. Smith J, Tho LM, Xu N, and Gillespie DA. The ATM-Chk2 and ATR-Chk1 pathways in DNA damage signaling and cancer. Adv Cancer Res 2010: 73-112, 2010
66. Spagnolo L, Rivera-Calzada A, Pearl LJ, and Llorca O. Three-dimensional structure of the human DNA-PKcs/ Ku7-/Ku80 complex assembled on DNA and its implications for DNA DSB repair. Mol Cell 22: 511-519, 2006 (Pubitemid 43740469)
67. Suzuki K, Kodama S, and Watanabe M. Recruitment of ATM protein to double strand DNA irradiated with ionizing radiation. J Biol Chem 274: 25571-25575, 1999
68. Tibbetts RS, Cortez D, Brumbaugh KM, Scully R, Livingston D, Elledge SJ, and Abraham RT. Functional interactions between BRCA1 and the checkpoint kinase ATR during genotoxic stress. Genes Dev 14: 2989-3002, 2000
69. Turner NC, Lord CJ, Iorns E, Brough R, Swift S, Elliott R, Rayter S, Tutt AN, and Ashworth A. A synthetic lethal siRNA screen identifying genes mediating sensitivity to a PARP inhibitor. EMBO J 27: 1368-1377, 2008 (Pubitemid 351655175)
70. Underhill C, Toulmonde M, and Bonnefoi H. A review of PARP inhibitors: from bench to bedside. Ann Oncol 22: 268- 279, 2011
71. Uziel T, Lerenthal Y, Moyal L, Andegeko Y, Mittelman L, and Shiloh Y. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J 22: 5612-5621, 2003 (Pubitemid 37279970)
72. Vermeulen K, Van Bockstaele DR, and Berneman ZN. The cell cycle: A review of regulation, deregulation, and therapeutic targets in cancer. Cell Prolif 36: 131-149, 2003 (Pubitemid 36808270)
73. Waldman T, Kinzler KW, and Vogelstein B. p21 is necessary for the p53-mediated G1 arrest in human cancer cells. Cancer Res 55: 5187, 1995
74. Walker JR, Corpina RA, and Goldberg J. Structure of the Ku heterodimer bound to DNA and its implications for double-strand break repair. Nature 412: 607-614, 2001 (Pubitemid 32772267)
75. Wang H, Shi LZ, Wong CCL, Han X, Hwang PYH, Truong LN, Zhu Q, Shao Z, Chen DJ, Berns MW, Yates JR III, Chen L, and Wu X. The interaction of CtIP and Nbs1 connects CDK and ATM to regulate HR-mediated double-strand break repair. PLoS Genet 9: e1003277, 2013
76. Wang H, Yang ES, Jiang J, Nowsheen S, and Xia F. DNA damage-induced cytotoxicity is dissociated from BRCA1's DNA repair function but is dependent on its cytosolic accumulation. Cancer Res 70: 6258-6267, 2010
77. Wang Y, Cortez D, Yazdi P, Neff N, Elledge SJ, and Qin J. BASC, a super complex of BRCA1-associated proteins involved in the recognition and repair of aberrant DNA structures. Genes Dev 14: 927-939, 2000 (Pubitemid 30253002)
78. Ward JF. DNA damage produced by ionizing radiation in mammalian cells: identities, mechanisms of formation and reparability. Prog Nucleic Acid Res Mol Biol 35: 95-125, 1988
79. Weterings E and Chen DJ. The endless tale of nonhomologous end-joining. Cell Res 18: 114-124, 2008
80. Wilson TE, Grawunder U, and Lieber MR. Yeast DNA ligase IV mediates non-homologous DNA end joining. Nature 388: 495-498, 1997 (Pubitemid 27328930)
81. Yamtich J and Sweasy JB. DNA polymerase family X: function, structure, and cellular roles. Biochim Biophys Acta 1804: 1136-1150, 2010
82. Yang ES, Nowsheen S, Wang T, Thotala DK, and Xia F. Glycogen synthase kinase 3b inhibition enhances repair of DNA double-strand breaks in irradiated hippocampal neurons. Neuro Oncol 13: 459-470, 2011
83. Yang ES, Wang H, Jiang G, Nowsheen S, Fu A, Hallahan DE, and Xia F. Lithium-mediated protection of hippocampal cells involves enhancement of DNA-PK-dependent repair in mice. J Clin Invest 119: 1124-1135, 2009
84. Yarden RI, Pardo-Reoyo S, Sgagias M, Cowan KH, and Brody LC. BRCA1 regulates the G2/M checkpoint by activating Chk1 kinase upon DNA damage. Nat Genet 30: 285-289, 2002
85. Yavuzer U, Smith GCM, Bliss T, Werner D, and Jackson SP. DNA end-independent activation of DNA-PK mediated via association with the DNA-binding protein C1D. Genes Dev 12: 2188-2199, 1998 (Pubitemid 28348042)
86. Yazlovitskaya EM, Edwards E, Thotala D, Fu A, Osusky KL, Whetsell WO, Boone B, Shinohara ET, and Hallahan DE. Lithium treatment prevents neurocognitive deficit resulting from cranial irradiation. Cancer Res 66: 11179-11186, 2006 (Pubitemid 46009945)
87. Yun MH and Hiom K. CtIP-BRCA1 modulates the choice of DNA double-strand break repair pathway throughout the cell cycle. Nature 459: 460-463, 2009
88. Zhang J, Willers H, Feng Z, Ghosh JC, Kim S, Weaver DT, Chung JH, Powell SN, and Xia F. Chk2 phosphorylation of BRCA1 regulates DNA double-strand break repair. Mol Cell Biol 24: 708-718, 2004 (Pubitemid 38057922)
89. Zimermann M, Lottersberger F, Buonomo SB, Sfeir A, and de Lange T. 53BP1 regulates DSB repair using Rif1 to control 5 end resection. Science 339: 700-704, 2013
90. Zou Y, Liu Y, Wu X, and Shell SM. Functions of human replication protein A (RPA): from DNA replication to DNA damage and stress responses. J Cell Phys 208: 267-273, 2006. (Pubitemid 43993416)